NIH Director Jay Bhattacharya, MD, PhD, was selected in February to also serve as acting director of the CDC, continuing the ...

Successful explantation of a corneal microlens for presbyopia and implantation of a trifocal IOL in a patient who developed ...

The FDA has, for a third time, declined to approve reproxalap for the treatment of dry eye disease, according to a press ...

Adults with moderate to severe plaque psoriasis saw the greatest mean quality-of-life gains with biologic therapy whereas home phototherapy offered lower costs for patients and payers, according to a ...

New long-acting muscarinic antagonist-long-acting beta agonist users had a decreased risk for a first moderate/severe COPD ...

Patients admitted to hospitals during periods of inadequate nurse staffing relative to typical levels experience ...

The reality of practicing medicine in 2026 is that potential liability exists in every specialty — and that, periodically, ...

The FDA approved icotrokinra for adults and adolescents aged 12 years and older with moderate to severe plaque psoriasis, ...

Between 2012 and 2023, there was a trend in total knee arthroplasty toward cementless fixation and an unresurfaced patellae, according to results presented here.“It appears that we are at a tipping ...

Experts from leading obesity organizations have published recommendations affirming the effectiveness, safety and ...

Chronic kidney disease affects millions of individuals worldwide and is frequently accompanied by profound declines in physical function, muscle mass and overall quality of life. Fatigue, reduced ...

Among adults with chronic rhinosinusitis with nasal polyps, those receiving verekitug vs. placebo at baseline and week 12 had ...